Aion Therapeutic Inc. reported earnings results for the third quarter and nine months ended January 31, 2023. For the third quarter, the company reported net loss was CAD 0.215721 million compared to CAD 0.650735 million a year ago. Basic loss per share from continuing operations was CAD 0.001 compared to CAD 0.005 a year ago. Diluted loss per share from continuing operations was CAD 0.001 compared to CAD 0.005 a year ago.
For the nine months, net income was CAD 0.466792 million compared to net loss of CAD 2.2 million a year ago. Basic earnings per share from continuing operations was CAD 0.003 compared to basic loss per share from continuing operations of CAD 0.016 a year ago. Diluted earnings per share from continuing operations was CAD 0.003 compared to diluted loss per share from continuing operations of CAD 0.016 a year ago.